Darin Hammers has over 30 years’ experience with increasing leadership roles in the medical device industry. Most recently, he served as CEO of DYSIS Medical from September 2018 – December 2022. Before joining DYSIS, Mr. Hammers served as the President and CEO of Cogentix Medical, acquired by Laborie in April 2018. He joined Cogentix’s predecessor company, Uroplasty, as Vice President of Global Sales in January 2013. During his time at Uroplasty, he was promoted to Chief Operating Officer before being named President and CEO in July 2016. Prior to joining Uroplasty, he was Vice President of Sales for Bard Medical Division of C.R. Bard based in Covington, GA, focused on Urology/Gynecology care products. Mr. Hammers also spent more than 12 years with Boston Scientific in various sales leadership positions and six years at ETHICON. He received his bachelor’s degree in Marketing from the University of Southern Indiana, and a master’s in Business Administration from Emory University – Goizueta Business School.
